Pharmaceutical Technology Europe
Last year, the global market for biological products exceeded $125 billion, accounting for 17% of the total market for pharma/biopharma products.
Alan Sheppard
Advertisement
Alan Sheppard is Principal, Thought Leadership, Global Generics at IMS Health.
Articles by Alan Sheppard
Advertisement
Latest Updated Articles
The Biosimilars Market Today And TomorrowSeptember 1st 2010
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
4
PharmTech Weekly Roundup—June 19, 2026
5